Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BP (British Petroleum) looks for ways to divest Vysis:

This article was originally published in Clinica

Executive Summary

UK oil company British Petroleum (BP) announced last week that it would like to dispose of its 65% share in Vysis that it inherited when it acquired the Amoco oil business in 1998. The company said that the DNA diagnostic company was not strategic and that it was looking for the best way to dispose of some or all of its holding and was considering selling privately, a further public offering or even a merger. BP has set no time limit on the transaction.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT072103

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel